Across TCGA pan-cancer cohorts, LINC00862 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC00862 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC00862 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00862 expression acts as an unfavorable survival marker.

BRCA and UCEC are the cancer types where LINC00862 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	All	0.099	0.903	<.001	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC00862 tumor-vs-normal RNA expression · all LINC00862 data types